ABCB1 single nucleotide polymorphisms in the Brazilian population

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 111-118

  Scheiner, Marcos Antonio Mauricio ^a   Damasceno, Arthur Motta ^a   Maia, Raquel Ciuvalschi ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

ABCB1 gene; Brazilian population; P glycoprotein; Polymorphisms

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BASE SEQUENCE; BRAZIL; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 77949261605     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9547-x     Document Type: Article

References (43)

1. EL Woodahl RJY Ho 2004 The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function Curr Drug Metab 5 11 19 10.2174/1389200043489108 10.2174/1389200043489108 1:CAS:528:DC%2BD2cXhvVCisL0%3D 14965248 (Pubitemid 38279406)
2. M Tanabe I Ieiri N Nagata, et al. 2001 Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of multidrug resistance (MDR)-1 gene JPET 297 1137 1143 1:CAS:528:DC%2BD3MXjvVShs7k%3D 0022-3565/01/2973-1137- 1143
3. TP Gonzalez M Schiengold JAB Chies 2006 Implicações clínicas dos polimorfismos do gene de resistência a múltiplas drogas MDR1 (ABCB1) Rev Bras Bioc 3 4 27 38 ISSN 1980-4849/pISSN1679-2343
4. AM Wielandt V Vollrath BJ Chinale 2004 Polimorfismos del gen de resistencia a múltiplas drogas (MDR1) em poblaciones chilenas: mapuche, mestiza y maorí Rev Méd Chile 132 1061 1068 15543762
5. J Vicente B Sinues A Fanlo, et al. 2007 Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards Mol Biol Rep 6 19 1:CAS:528: DC%2BD2sXht1CrsrnM ISSN 0301-4851/ISSN1573-4978
6. S Hoffmeyer O Burk O von Richter, et al. 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 3473 3478 10.1073/pnas.050585397 10.1073/pnas. 050585397 1:CAS:528:DC%2BD3cXitlWqtL8%3D 10716719 (Pubitemid 30183327)
7. RB Kim BF Leake EF Choo, et al. 2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans Clin Pharmacol Ther 70 189 199 10.1067/mcp.2001.117412 10.1067/mcp.2001.117412 1:CAS:528:DC%2BD3MXmslygs7o%3D 11503014 (Pubitemid 32777772)
8. K Jamroziak W Mlinarski E Balcerczak, et al. 2004 Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia Eur J Haematol 72 314 321 10.1111/j.1600-0609.2004.00228.x 10.1111/j.1600-0609.2004.00228.x 1:CAS:528:DC%2BD2cXkt1Kgu7w%3D 15059065 (Pubitemid 38520728)
9. E Schaeffeler M Eichelbaum U Brinckmann, et al. 2001 Frequency of C3435T polymorphism of MDR1 gene in African people Lancet 358 383 384 10.1016/S0140-6736(01)05579-9 10.1016/S0140-6736(01)05579-9 1:CAS:528: DC%2BD3MXlvFWhu7g%3D 11502320 (Pubitemid 32739101)
10. MM Ameyaw F Regateiro T Li, et al. 2001 MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity Pharmacogenectics 11 217 221 10.1097/00008571-200104000-00005 10.1097/00008571-200104000-00005 1:CAS:528:DC%2BD3MXjs1Sru7Y%3D (Pubitemid 32319871)
11. K Ramasamy SS Sam A Chandrasekaran 2006 Allele and genotype frequency of MDR1 C3435T in Tamillian population Drug Metab Pharmacokinet 21 506 508 10.2133/dmpk.21.506 10.2133/dmpk.21.506 1:CAS:528:DC%2BD2sXis12jurg%3D 17220567
12. T Nakamura T Sakaeda M Horinouchi, et al. 2002 Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects Clin Pharmacol Ther 71 297 303 10.1067/mcp.2002.122055 10.1067/mcp.2002.122055 1:CAS:528:DC%2BD38Xjs1ertrw%3D 11956513 (Pubitemid 34311459)
13. N Bebek N Çine GO Öner, et al. 2005 Genotype and allele frequencies of MDR-1 C3435T polymorphism in Turkish population J Neurol Sci 22 261 266 ISSN 1300-1817/ISSN1302-1664
14. K Jamroziack E Balcerczak W Mlynarski, et al. 2002 Distribution of Allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population Pol J Pharmacol 54 495 500
15. RT Calado RP Falcão AB Garcia, et al. 2002 Influence of functional MDR1 gene polimorphisms on P-glycoprotein activity in CD34 + hematopoietic stem cells Haematologica 87 564 568 1:CAS:528:DC%2BD38XlsFCit70%3D 12031911
16. M Fiegenbaum FR da Silveira CR Van der Sand, et al. 2005 The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment Clin Pharmacol Ther 78 551 558 10.1016/j.clpt.2005.08.003 10.1016/j.clpt.2005.08.003 1:CAS:528: DC%2BD2MXht1OltLfM 16321621 (Pubitemid 41698910)
17. AC Rodrigues IM Rebecchi MC Bertolami, et al. 2005 High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descendent Braz J Med Biol Res 38 1389 1397 1:CAS:528:DC%2BD2MXhtFSntrvL 16138223
18. I Cascorbi T Gerloff A Johne, et al. 2001 Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects Clin Pharmacol Ther 69 169 174 10.1067/mcp.2001.114164 10.1067/mcp.2001.114164 1:CAS:528:DC%2BD3MXislylsb0%3D 11240981 (Pubitemid 32225417)
19. RL Roberts PR Joyce RT Mulder, et al. 2002 A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression Pharmacogenomics J 2 191 196 10.1038/sj.tpj.6500099 10.1038/sj.tpj.6500099 1:CAS:528:DC%2BD38XkslKmtb0%3D 12082591 (Pubitemid 34982226)
20. C Komoto T Nakamura T Sakaeda, et al. 2006 MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer Drug Metab Pharmacokinet 21 126 132 10.2133/dmpk.21.126 10.2133/dmpk.21.126 1:CAS:528:DC%2BD28Xmt1aku70%3D 16702732
21. D Li GL Zhang YQ Lou, et al. 2007 Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups J Clin Pharm Ther 32 89 95 10.1111/j.1365-2710.2007.00791 10.1111/j.1365-2710.2007.00791.x 17286792
22. ALHJ Aarnoudse RHN van Schaik J Dieleman, et al. 2006 MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine Clin Pharmacol Ther 10 367 374 10.1016/j.clpt.2006.07.003 10.1016/j.clpt.2006. 07.003 (Pubitemid 44479754)
23. W Siegmund K Ludwig T Giessman, et al. 2002 The effects of human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol Clin Pharmacol Ther 72 572 583 10.1067/mcp.2002.127739 10.1067/mcp.2002.127739 1:CAS:528:DC%2BD38XpsFSisbo%3D 12426521 (Pubitemid 36237729)
24. K Pechandová H Buzková O Slanař, et al. 2006 Polymorphysms of the MDR1 gene in the Czech population Folia Biol (Praha) 52 184 189
25. E-K Tan M Drozdzik M Bialecka, et al. 2004 Analysis of MDR1 haplotypes in Parkinson's disease in a white population Neurosci Lett 372 240 244 10.1016/j.neulet.2004.09.046 10.1016/j.neulet.2004.09.046 1:CAS:528: DC%2BD2cXpslOktL4%3D 15542248 (Pubitemid 39470204)
26. T Fiedler C Büning W Reuter, et al. 2007 Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease Eur J Clin Pharmacol 63 917 925 10.1007/s00228-007-0334-0 10.1007/s00228-007-0334-0 1:STN:280:DC%2BD2srisVWlsQ%3D%3D 17665184 (Pubitemid 47387906)
27. C Balram A Sharma C Sivathasan, et al. 2003 Frequency of C3435T single nucleotide polymorphism in an Asian population: phenotypic-genotypic correlates J Clin Pharmacol 56 78 83 10.1046/j.1365-2125.2003.01820.x 1:CAS:528: DC%2BD3sXmvFSls7k%3D (Pubitemid 36886491)
28. LK Teh WL Lee J Amir, et al. 2007 Single step PCR for detection of allelic variation of MDR1 gene (P-glycoprotein) among three ethnic groups in Malaysia J Clin Pharm Ther 32 313 319 10.1111/j.1365-2710.2007.00822.x 10.1111/j.1365-2710.2007.00822.x 1:CAS:528:DC%2BD2sXmvVWmsLg%3D 17489883 (Pubitemid 46699519)
29. C3435T polymorphism in the Han population of China Swiss Med Wkly 136 377 382 1:CAS:528:DC%2BD28XntVClsrs%3D 16847760 (Pubitemid 43962689)
30. PM Mrozikiewicz A Seremak-Mrozikiewicz A Semczuk, et al. 2007 The significance of C3435T point mutation of the MDR1 gene in endometrial cancer Int J Gyn Can 17 705 734 10.1111/j.1525-1438.2007.00843.x 10.1111/j.1525-1438.2007. 00843.x (Pubitemid 46744007)
31. ML Bernal S Blanca A Fanlo, et al. 2003 Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population Ther Drug Monit 25 107 111 10.1097/00007691-200302000-00016 10.1097/00007691-200302000-00016 1:CAS:528:DC%2BD3sXmtVWntA%3D%3D 12548153 (Pubitemid 36139834)
32. S Turgut G Turgut EÖ Atalay 2006 Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizle province of Turkey Mol Biol Rep 33 295 300 10.1007/s11033-006-9022-x 10.1007/s11033-006- 9022-x 1:CAS:528:DC%2BD28Xht1Sgu7rK 17080296 (Pubitemid 44760400)
33. T Sakaeda T Nakamura K Okimura 2002 MDR1 genotype-related pharmacokinetics and pharmacodynamics Biol Pharm Bull 25 1391 1400 10.1248/bpb.25.1391 10.1248/bpb.25.1391 1:CAS:528:DC%2BD38XptlGlu74%3D 12419946 (Pubitemid 39663152)
34. T Osuga T Sakaeda T Nakamura, et al. 2006 MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese Biol Pharm Bull 29 324 329 10.1248/bpb.29.324 10.1248/bpb.29.324 1:CAS:528:DC%2BD28XjslyqsL4%3D 16462040
35. SI Hamdy M Hiratsuka K Narahara, et al. 2003 Genotype and allele frequencies to TPMT, NAT2, GST, SULTIAI and MDR-1 in the Egyptian population Br J Clin Pharmacol 55 560 569 10.1046/j.1365-2125.2003.01786.x 10.1046/j.1365-2125.2003.01786.x 1:CAS:528:DC%2BD3sXlvFait7k%3D 12814450 (Pubitemid 36783197)
36. B Chowbay S Cumaraswamy YB Cheung, et al. 2003 Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients Pharmacogenetics 13 89 95 10.1097/00008571-200302000-00005 10.1097/00008571-200302000-00005 1:CAS:528:DC%2BD3sXot1Khug%3D%3D 12563178 (Pubitemid 36259588)
37. FC Parra RC Amado JR Lambertucci, et al. 2003 Color and genomic ancestry in Brasilians Proc Natl Acad Sci USA 100 177 182 10.1073/pnas.0126614100 10.1073/pnas.0126614100 1:CAS:528:DC%2BD3sXktlOgtg%3D%3D 12509516 (Pubitemid 36078048)
38. K Oselin T Gerloff PM Mrozikiewicz, et al. 2003 MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes Fundam Clin Pharmacol 17 463 469 10.1046/j.1472-8206.2003.00163.x 10.1046/j.1472-8206.2003.00163.x 1:CAS:528:DC%2BD3sXlvFCnt7c%3D 12914549 (Pubitemid 36920648)
39. A Owen C Goldring P Morgan, et al. 2005 Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver Br J Clin Pharmacol 59 3 365 370 10.1111/j.1365-2125.2005.02229.x 10.1111/j.1365-2125.2005.02229.x 1:CAS:528:DC%2BD2MXjtVOnsrs%3D 15752383 (Pubitemid 40388091)
40. T lllmer US Schuler C Thiede, et al. 2002 MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients Can Res 62 4955 4962
41. JJ Lourenço RC Maia MAM Scheiner, et al. 2008 Genomic variation at the MDR-1 promoter and P-glycoprotein expression and activity in AML patients Leuk Res 32 976 979 10.1016/j.leukres.2007.10.001 10.1016/j.leukres.2007.10.001 18001833
42. G Sanchez D Bittencourt K Laude J Barbier, et al. 2008 Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer Proc Natl Acad Sci USA 105 6004 6009 10.1073/pnas.0710748105 10.1073/pnas.0710748105 1:CAS:528:DC%2BD1cXltlGit7c%3D 18413612 (Pubitemid 351758389)
43. AA Komar 2007 Silent SNP: impact on gene function and phenotype Pharmacogenomics 8 1075 1080 10.2217/14622416.8.8.1075 10.2217/14622416.8.8.1075 1:CAS:528:DC%2BD2sXpsFKlsrc%3D 17716239 (Pubitemid 47423694)